On improving assessment of in-hospital mortality and ICU admisison in community-acquired pneumonia patients by using the e-CURB Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012
3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors Source: Eur Respir J 2016; 47:1572-1574 Year: 2016
Predictive factors of in-hospital mortality of patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 352s Year: 2006
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2 Source: Eur Respir J, 56 (3) 2002961; 10.1183/13993003.02961-2020 Year: 2020
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2 Source: Eur Respir J, 56 (3) 2002439; 10.1183/13993003.02439-2020 Year: 2020
Analysis of the mortality caused by community-acquired pneumonia in the elderly Source: Eur Respir J 2005; 26: Suppl. 49, 544s Year: 2005
Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009
The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Factors associated with community-acquired pneumonia in-hospital mortality in Portugal Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021
Correlation between pneumonia severity index and mortality within 30 days after the diagnosis of community-acquired pneumonia in elderly subjects Source: Eur Respir J 2006; 28: Suppl. 50, 741s Year: 2006
Macrolide therapy is associated with lower 30-day mortality in patients with non-pneumonia and pneumonia severe sepsis Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011
Mortality in patients with ventilator-associated pneumonia (VAP) and severe sepsis is determined by the number of organ failures Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
Analysis of causes of death and mortality risk factors in elderly patients hospitalized due to pneumonia Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018
Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008
Incidence of pneumonia in patients after stroke Source: Eur Respir J 2006; 28: Suppl. 50, 351s Year: 2006
Factors influencing in-hospital mortality in community-acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 352s Year: 2006
Inflammatory responses predict long-term mortality risk in community-acquired pneumonia Source: Eur Respir J 2011; 37: 1439-1446 Year: 2011
Community-acquired pneumonia requiring hospitalization in HIV-infected patients Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 groups at risk Source: Eur Respir J 2007; 30: Suppl. 51, 481s Year: 2007
Analysis of mortality from community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 376s Year: 2006